Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02061553 · ClinicalTrials.gov registry record · NA

SMS Messaging to Reduce Depression and Anxiety Following TBI

A NA study of Traumatic Brain Injury, sponsored by Albert Einstein Healthcare Network.

Completed
Registry status
NA
Development phase
119
Enrollment target
1
Study location

NCT02061553 is a NA study of Traumatic Brain Injury that has completed, run by Albert Einstein Healthcare Network. The registered enrollment target is 119 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02061553, a NA study of Traumatic Brain Injury, has completed, sponsored by Albert Einstein Healthcare Network.

COMPLETED
Registry status
NA
Development phase
119 participants
Enrollment target
1
Study location

Study Summary

This investigation addresses emotional health in community dwelling persons with traumatic brain injury (TBI). It is designed to test the efficacy of a novel behavioral treatment for depression and anxiety symptoms. This treatment incorporates principles of Behavioral Activation (BA), a promising treatment model for depression and anxiety after TBI, and implementation intentions, a theoretically motivated method to enhance enactment of goal-relevant behaviors via action planning. To maximize the impact of this intervention over time, we use the low-cost, widely available technology of SMS, or text messaging, to promote positive behavior change in accordance with planned values and intentions. Participants are randomized 1:2:2 to one of three conditions. Condition 1: a control condition in which participants receive SMS messages with self-selected motivational statements. Condition 2: a condition using BA-based implementation intentions. Condition 3: a condition using BA-based activity monitoring and scheduling based on personal values.

Conditions Studied

Interventions

  • BEHAVIORAL Motivation
  • BEHAVIORAL Intention
  • BEHAVIORAL BA-Tech

Study Locations (1)

Pennsylvania

  • Moss Rehabilitation Research Institue - Elkins Park

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2013-10-22
Est. Completion 2023-07-13
Phase NA

Sponsor

Albert Einstein Healthcare Network

48 total trials

What the Registry Record Tells You About NCT02061553

The ClinicalTrials.gov registry entry for NCT02061553 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (57% lower). The listed sponsor is Albert Einstein Healthcare Network, which has 48 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 3 interventions - of which Motivation is the first listed.

NCT02061553 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02061553 about?

NCT02061553 is a clinical study titled "SMS Messaging to Reduce Depression and Anxiety Following TBI". This investigation addresses emotional health in community dwelling persons with traumatic brain injury (TBI). It is designed to test the efficacy of a novel behavioral treatment for depression and anxiety symptoms. This treatment incorporates principles of Behavioral Activation (BA), a promising tr...

What is the current status of trial NCT02061553?

This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2013-10-22. Estimated completion is 2023-07-13.

What conditions does trial NCT02061553 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT02061553?

The interventions under investigation include: Motivation (BEHAVIORAL), Intention (BEHAVIORAL), BA-Tech (BEHAVIORAL).

Who is sponsoring clinical trial NCT02061553?

This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02061553 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.